Fulcrum Therapeutics (FULC) Total Liabilities (2019 - 2025)
Historic Total Liabilities for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $16.5 million.
- Fulcrum Therapeutics' Total Liabilities fell 2405.95% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year decrease of 2405.95%. This contributed to the annual value of $17.7 million for FY2024, which is 2140.79% down from last year.
- Fulcrum Therapeutics' Total Liabilities amounted to $16.5 million in Q3 2025, which was down 2405.95% from $14.5 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Total Liabilities peaked at $34.5 million during Q2 2022, and registered a low of $14.2 million during Q1 2025.
- In the last 5 years, Fulcrum Therapeutics' Total Liabilities had a median value of $23.5 million in 2021 and averaged $23.3 million.
- In the last 5 years, Fulcrum Therapeutics' Total Liabilities plummeted by 3301.64% in 2021 and then soared by 2774.83% in 2022.
- Over the past 5 years, Fulcrum Therapeutics' Total Liabilities (Quarter) stood at $23.5 million in 2021, then increased by 18.25% to $27.7 million in 2022, then dropped by 18.89% to $22.5 million in 2023, then decreased by 21.41% to $17.7 million in 2024, then fell by 6.74% to $16.5 million in 2025.
- Its Total Liabilities stands at $16.5 million for Q3 2025, versus $14.5 million for Q2 2025 and $14.2 million for Q1 2025.